Hansongneotech

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 6, 2021	PDC*line Pharma	$26.2M Grant / Series B	Sangwoo Lee	Alpha Holdings, Brain Asset Management, Noshaq, Sambrinvest, Fontaine François, Smart Korea UTC Bio-Healthcare Venture Fund, SRIW, Walloon Region

Total Raised

N/A

Valuation

N/A